IP Library Granted Patent US 8,231,896
Granted Patent B2
US 8,231,896 · App. 10/984,205 · Granted Jul 31, 2012

Non-gelatin soft capsule system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,231,896
App. No.
10/984,205
Granted
Jul 31, 2012
Kind
B2
Abstract

A non-gelatin encapsulation system for liquid filled soft capsules, by nature of the carrier, the cationic-ionic balance of the carrier and the active ingredients, or the concentration of the active ingredients and excipients, are difficult or impossible to commercially encapsulate in gelatin capsules. In particular, the system is adapted for the encapsulation of highly basic, or alkaline, fills. The system provides for a predominantly starch and gelling carrageenan based shell, which displays high resistance to both concentrated fills and to alkaline fills, in particular, to those fills which contain the salt or salts of weak acids and strong bases.

Claims (47)

1. A non-gelatin soft capsule system for encapsulating chemical compounds, said non-gelatin soft capsule system comprising:

a shell comprising a modified starch or a native potato starch and a gelling carrageenan, wherein a weight to weight ratio of starch to gelling carrageenan is between 1.5 to 1 and 5 to 1; and

a fill, said fill comprising:

at least one acidic active ingredient dissolved or dispersed in at least one carrier, and

an alkali agent sufficient to partially neutralize a portion of said at least one acidic active ingredient by forming an equilibrium between (1) said acidic active ingredient and (2) the salt of said acidic active ingredient and said alkali agent,

wherein the fill has a pH greater than 7.5, and

wherein the shell exhibits resistance to degradation caused by alkaline fills.

2. The non-gelatin soft capsule system according to claim 1 , wherein said fill has a pH greater than about 8.0.

3. The non-gelatin soft capsule system according to claim 1 , wherein said fill has a pH between about 8.0 and about 12.0.

4. The non-gelatin soft capsule system according to claim 1 , wherein said shell further comprises water, a plasticizer and a buffer.

5. The non-gelatin soft capsule system according to claim 1 , wherein said starch and said gelling carrageenan are at a weight to weight ratio of at least 2 to 1.

6. The non-gelatin soft capsule system according to claim 1 , wherein said starch and said gelling carrageenan are at a weight to weight ratio of at least 3 to 1.

7. The non-gelatin soft capsule system according to claim 4 , wherein said gelling carrageenan comprises iota-carrageenan.

8. The non-gelatin soft capsule system according to claim 4 , wherein the modified starch is selected from the group consisting of hydroxypropylated tapioca starch, hydroxypropylated maize starch, acid thinned hydroxypropylated corn starch, and pregelatinized modified corn starches, and wherein said starch has a hydration temperature below about 90 degrees Centigrade.

9. The non-gelatin soft capsule system according to claim 1 , wherein said at least one active ingredient is ibuprofen.

10. The non-gelatin soft capsule system according to claim 9 , wherein said ibuprofen is present in the non-gelatin soft capsule system in a weight to weight volume of at least 40%.

11. The non-gelatin soft capsule system according to claim 1 , wherein an amount of said alkali agent is sufficient to neutralize more than 40% of said acidic active ingredient.

12. The non-gelatin soft capsule system according to claim 11 , wherein an amount of said alkali agent is sufficient to neutralize more than 60% of the acidic active ingredient.

13. The non-gelatin soft capsule system according to claim 12 , wherein an amount of said alkali agent is sufficient to neutralize more than 80% of said acidic active ingredient.

14. The non-gelatin soft capsule system according to claim 13 , wherein an amount of said alkali agent is sufficient to neutralize more than 95% of the acidic active ingredient.

15. A non-gelatin soft capsule system for encapsulating chemical compounds, said non-gelatin soft capsule system comprising:

a shell comprising a modified starch and iota-carrageenan,

wherein the modified starch and the iota-carrageenan are at a weight to weight ratio of between at least 1.5 to 1 and 5.0 to 1,

wherein the modified starch is selected from the group consisting of hydroxypropylated tapioca starch, hydroxypropylated maize starch, acid thinned hydroxypropylated corn starch, potato starch, and pregelatinized modified corn starches,

wherein said modified starch has a hydration temperature below about 90 degrees Centigrade, and

wherein the shell exhibits resistance to degradation caused by alkaline fills; and

a fill, said fill comprising at least one acidic active ingredient dissolved or dispersed in at least one carrier, and

an alkali agent sufficient to partially neutralize a portion of said acidic active ingredient by forming an equilibrium between (1) the acidic active ingredient and (2) the salt of said acidic active ingredient and said alkali agent,

wherein the fill has a pH greater than about 8.0.

16. A soft capsule system for encapsulating chemical compounds, said non-gelatin soft capsule system comprising:

a shell comprising modified starch, iota-carrageenan, water, a plasticizer, and a buffer,

wherein the modified starch is selected from the group consisting of hydroxypropylated tapioca starch, hydroxypropylated maize starch, acid thinned hydroxypropylated corn starch, potato starch, and pregelatinized modified corn starches,

wherein said modified starch has a hydration temperature below about 90 degrees Centigrade,

wherein the modified starch and the iota-carrageenan are at a weight to weight ratio of at least 3 to 1, and

wherein the shell exhibits resistance to degradation caused by alkaline fills; and

a fill, said fill comprising at least one acidic active ingredient dissolved or dispersed in at least one carrier, and

an alkali agent sufficient to partially neutralize a portion of said at least one acidic active ingredient by forming an equilibrium between (1) said acidic active ingredient and (2) the salt of said acidic active ingredient and said alkali agent,

wherein said fill has a pH between about 8.0 and 12.0.

17. A soft capsule system for encapsulating chemical compounds, said non-gelatin soft capsule system comprising:

a shell comprising modified starch, iota-carrageenan, water, a plasticizer, and a buffer,

wherein the shell includes a mixture of modified starches selected from the group consisting of hydroxypropylated tapioca starch, hydroxypropylated maize starch, acid thinned hydroxypropylated corn starch, potato starch, and pregelatinized modified corn starches,

wherein said modified starch has a hydration temperature below about 90 degrees Centigrade,

wherein said modified starch and said iota-carrageenan are at a weight to weight ratio of at least 3 to 1, and wherein the shell exhibits resistance to degradation caused by alkaline fills; and

a fill, said fill comprising at least one acidic active ingredient dissolved or dispersed in at least one carrier, and

an alkali agent sufficient to partially neutralize a portion of said at least one acidic active ingredient by forming an equilibrium between (1) said acidic active ingredient and (2) the salt of said acidic active ingredient and said alkali agent,

wherein the fill has a pH between about 8.0 and 12.0, and

wherein the at least one active ingredient is selected from the group consisting of ibuprofen, acetaminophen, and naproxen.

Assignments (3)
SECURITY INTEREST Recorded Dec 19, 2024
From: CATALENT CTS (KANSAS CITY), LLC; REDWOOD BIOSCIENCE, INC.; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT WELLNESS, LLC; CATALENT PHARMA SOLUTIONS, INC.; CATALENT WELLNESS NEW JERSEY, LLC; CATALENT MARYLAND, INC.; CATALENT GREENVILLE, INC.; CATALENT MICRON TECHNOLOGIES, INC.; CATALENT SAN DIEGO, INC.; CATALENT WELLNESS VIRGINIA, LLC; CATALENT USA PACKAGING, LLC; CATALENT PHARMA SOLUTIONS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069743/0458 →
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL (019323/0302) Recorded Dec 19, 2024
From: JPMORGAN CHASE BANK, N.A.
To: CATALENT PHARMA SOLUTIONS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; R.P. SCHERER TECHNOLOGIES, LLC; R.P. SCHERER CORPORATION
Reel/Frame 069750/0933 →
NOTICE OF SUCCESSION OF AGENCY Recorded May 17, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 049217/0981 →